Fadogia Agrestis

Fadogia agrestis is a West African shrub whose stem extract has been used traditionally as an aphrodisiac and, more recently, adopted by the looksmaxxing and natty-T community as a Leydig-cell stimulator. The honest framing: its mechanism is inferred, not proven. There is no human receptor-binding data, no cell-line work, and no validated target. What we have is a handful of rat studies from the same Nigerian lab and a plausible saponin-driven hypothesis shared with other Rubiaceae and Fabaceae botanicals.

Here's what that inference actually looks like.

Proposed LH-Mimetic / Leydig-Cell Stimulation#

The central hypothesis — and the reason anyone takes this herb — is that Fadogia's saponin fraction signals through the Leydig-cell steroidogenic pathway, functionally imitating luteinizing hormone (LH) and pushing testosterone synthesis downstream. In rats, oral aqueous stem extract produced a clean dose-response curve in both behaviour and serum T:

"Oral administration of the extract (18, 50 and 100 mg/kg body weight) significantly increased mount frequency, intromission frequency, and serum testosterone concentration in male rats in a dose-dependent manner." — Yakubu MT, Akanji MA, Oladiji AT, Asian Journal of Andrology (2005)

Practically, this is what the community is chasing: a mild, non-suppressive nudge to endogenous T that supports libido, morning wood, gym drive, and aggression. Whether the LH-mimetic framing is literally correct or whether the extract acts further downstream (e.g. enhancing StAR protein expression or P450scc activity in Leydig cells) has not been resolved in any published work.

Saponin-Driven Steroidogenesis#

The active fraction is almost certainly the triterpenoid saponins, not the alkaloids or anthraquinones. This is the same mechanistic lane proposed for Bulbine natalensis, Tribulus terrestris, and other folk aphrodisiacs in the Rubiaceae/Fabaceae families:

"The saponin component... may have played a significant role in mediating the observed increases in serum testosterone level, a mechanism also proposed for some other members of the Rubiaceae and Fabaceae families." — Yakubu MT, Afolayan AJ, Pharmaceutical Biology (2010)

This matters for sourcing: a Fadogia product that doesn't concentrate the saponin fraction is probably inert. Bulk powder with no standardization claim is a coin flip. The 10:1 stem extract that dominates the market is an attempt to enrich this fraction, though third-party verification of saponin content is rare.

Dose-Dependent Leydig Stress — The Flip Side of the Same Mechanism#

The same machinery that makes Fadogia interesting is why it has a ceiling. Push Leydig cells hard enough, long enough, and the rat data shows tissue-level damage:

"There was a significant reduction in testicular weight, testicular glycogen, and activities of marker enzymes including ALP, ACP and LDH after 28 days of Fadogia agrestis extract administration, suggesting possible testicular and Leydig cell stress at higher doses." — Yakubu MT, Akanji MA, Oladiji AT, Journal of Ethnopharmacology (2008)

This is the mechanistic argument for cycling (8 on / 2 off) and capping around 600 mg/day. The acute steroidogenic push and the chronic tubular/Leydig stress are two sides of the same saponin signal — you cannot take the first without risking the second if it is run continuously. Anecdotal human reports of dull testicular ache around weeks 3–6 line up neatly with this model, even if they're not proof of it.

Possible Hepatic and Enzymatic Involvement#

A secondary mechanism — less studied but consistent with the anecdotal bloodwork drift the community reports — is first-pass hepatic metabolism of the saponin load. Triterpenoid saponins are broadly known to interact with hepatic enzyme systems, and Fadogia's 28-day rat data showed shifts in liver and kidney enzyme markers alongside the testicular findings (Yakubu 2008). Community reports echo this at the high end of dosing:

"A community member reported running Fadogia at 600 mg for 8 weeks and experiencing a dull testicular ache midway through. Bloodwork showed slightly elevated liver enzymes, which returned to normal a few weeks after stopping." — r/Supplements community report (2024)

The practical implication: don't stack Fadogia with 17α-alkylated orals or other hepatotoxic compounds without spaced liver panels. The Fadogia hepatic signal isn't characterized well enough to share a cycle with Superdrol, Anadrol, or tbol without risking attribution confusion — and compounded hepatic load — at worst.

What the Mechanism Is Not#

A few things Fadogia almost certainly does not do, despite marketing claims:

• It is not an aromatase inhibitor. No data support AI activity; don't use it to manage estradiol on cycle.
• It is not a SARM or AR modulator. There is no binding data at the androgen receptor.
• It is not a 5α-reductase inhibitor or DHT modulator. It has no known relevance to hair, prostate, or scalp androgen dynamics.
• It is not a replacement for a SERM-based PCT. Whatever Leydig-stimulating effect it has is modest and does not substitute for clomiphene/enclomiphene/tamoxifen after a suppressive AAS cycle. Treat it as an adjunct at best.

The honest read: Fadogia's mechanism is a plausible but unverified saponin-mediated Leydig push, with a built-in ceiling imposed by the same pathway. Used cycled at 600 mg with tongkat ali, it's a reasonable natty-T lever. Used year-round at max doses, you are personally beta-testing the rat toxicity curve.

Common (most users)#

• Mild GI discomfort / loose stools — dose with food (a real meal, not just coffee). If it persists, split the dose AM/midday or drop to 450 mg.
• Insomnia or sleep fragmentation — dose-related and timing-related. Keep it pre-noon. Never dose in the evening.
• Mild jitteriness / elevated resting HR — back off 150 mg and reassess. Some users conflate this with "it's working"; it isn't, it's just stimulation.
• Initial libido spike followed by flattening — the 2-week washout in the 8-on/2-off protocol exists specifically to reset this. Respect the washout.
• Dry mouth / mild headache — hydration and electrolytes. Usually resolves within the first 5–7 days.

Uncommon (dose-dependent or individual)#

• Dull testicular ache — most commonly reported at 900–1200 mg or beyond week 6 at 600 mg. This is the human echo of the rat Leydig-stress data and is not to be worked through. Stop, washout, restart lower if at all.

"A community member reported running Fadogia at 600 mg for 8 weeks and experiencing a dull testicular ache midway through. Bloodwork showed slightly elevated liver enzymes, which returned to normal a few weeks after stopping." — r/Supplements (2024)

• Elevated ALT/AST — pull a metabolic panel at week 6. Mild drift (under 1.5× ULN) in isolation usually resolves post-washout. If you're stacking orals, assume Fadogia is contributing and do not dismiss it as "just the oral."
• Paradoxical libido crash — weeks 5–8 in long runs. Signal that Leydig output is fatiguing. Stop the cycle, don't push through.
• Blood pressure creep — worth a cuff check at week 4 if you're already on AAS or PDE5 inhibitors.
• Mood irritability / short fuse — some responders feel this alongside the T bump. If partners are noticing it before you are, drop the dose.

Rare but serious#

• Clinically significant LFT elevation (>3× ULN) — stop immediately, recheck in 4 weeks, do not restart until normalized. Rule out other hepatotoxic inputs (orals, alcohol, acetaminophen).
• Persistent testicular pain or swelling — stop and see a urologist. The rat histology data (Yakubu 2008) shows reduced testicular weight and altered ALP/ACP/LDH at chronic dosing; take testicular symptoms literally.

"There was a significant reduction in testicular weight, testicular glycogen, and activities of marker enzymes including ALP, ACP and LDH after 28 days of Fadogia agrestis extract administration, suggesting possible testicular and Leydig cell stress at higher doses." — Yakubu et al., J Ethnopharmacol (2008)

• Suppressed total T on post-run bloodwork — rare but documented anecdotally after long uncycled runs. Treat as HPTA/Leydig fatigue; do a proper washout and recheck at 6–8 weeks. Do not immediately stack another T-pushing compound on top.

Hard contraindications#

• Trying to conceive — the rat testicular-toxicity signal is a direct warning about spermatogenesis. Do not run Fadogia if you or your partner are planning conception in the next 6 months.
• Pregnancy or lactation — no data, unknown teratogenicity, avoid entirely.
• Existing hepatic impairment — any elevated baseline LFTs, fatty liver, or history of drug-induced hepatitis. Pick a different lever.
• Concurrent oral AAS (Superdrol, anadrol, tbol, winstrol, dbol) — do not add unvalidated hepatotoxic load on top of a 17α-alkylated compound. Save Fadogia for off-cycle.
• Continuous year-round use — every protocol with any evidence behind it, including Huberman's 600 mg / 8-on-2-off, bakes in a washout. The rat data is why. Cycling is non-negotiable.
• Women — no human or animal data in females. Off-label female use is entirely unstudied. Avoid.

Gender, conception & PCT notes#

Male fertility: The most defensible concern with Fadogia is spermatogenic. The 28-day rat study showed reduced testicular weight and disrupted testicular enzymology at all three doses tested (Yakubu 2008). If conception is on the table in the next 6–12 months, this is not your compound — run tongkat ali solo, or nothing at all, and re-evaluate after your partner is pregnant.

Women: Zero human or animal data in females. The entire published literature is male rats. Off-label female use is uncharacterized — avoid.

PCT: Fadogia is not a PCT. It is, at best, an adjunct layered onto a real SERM protocol (enclo, clomid, or nolvadex) at 600 mg/day for 4–6 weeks. Running it as standalone post-cycle therapy is how HPTA recovery stalls at week 6 with closed bloods. Use the SERM as your backbone; Fadogia is a side dish.

Bloodwork cadence: baseline (total T, free T, LH, FSH, E2, SHBG, ALT, AST, lipids) before the first run, week 6 recheck on the first cycle to confirm responder status and catch liver drift, and an annual repeat if cycling long-term. Cycled intelligently at 600 mg with blood to back it up, Fadogia is a reasonable natty lever. Un-cycled at 1200 mg stacked with orals and no labs, it becomes the reason the rat testicular data exists.